89 related articles for article (PubMed ID: 2683975)
1. [Prognostic factors of differentiated thyroid cancers. 536 cases].
Tourniaire J; Bernard-Auger MH; Adeleine P; Milan JJ; Fleury-Goyon MC; Dutrieux-Berger N
Ann Endocrinol (Paris); 1989; 50(3):219-24. PubMed ID: 2683975
[TBL] [Abstract][Full Text] [Related]
2. [Differentiated carcinoma of the thyroid gland in an area of endemic goiter. Clinical study and prognostic correlation].
Mato A; Gippini A; Peino R; Gayoso P; Uriel B
An Med Interna; 1996 Nov; 13(11):537-40. PubMed ID: 9019212
[TBL] [Abstract][Full Text] [Related]
3. Multivariate study of prognostic factors for differentiated thyroid carcinoma: the significance of histologic subtype.
Noguchi M; Mizukami Y; Michigishi T; Koyasaki N; Ohta N; Miyazaki I
Int Surg; 1993; 78(1):10-5. PubMed ID: 8473075
[TBL] [Abstract][Full Text] [Related]
4. The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma.
Tsang RW; Brierley JD; Simpson WJ; Panzarella T; Gospodarowicz MK; Sutcliffe SB
Cancer; 1998 Jan; 82(2):375-88. PubMed ID: 9445196
[TBL] [Abstract][Full Text] [Related]
5. Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: a retrospective analysis of 700 patients.
Loh KC; Greenspan FS; Gee L; Miller TR; Yeo PP
J Clin Endocrinol Metab; 1997 Nov; 82(11):3553-62. PubMed ID: 9360506
[TBL] [Abstract][Full Text] [Related]
6. [Total thyroidectomy of choice in papillary microcarcinoma].
Pisello F; Geraci G; Sciumè C; Li Volsi F; Modica G
G Chir; 2007; 28(1-2):13-9. PubMed ID: 17313727
[TBL] [Abstract][Full Text] [Related]
7. Well-differentiated thyroid carcinoma: factors predicting recurrence and survival.
Lim LH; Soo KC; Chong YK; Gao F; Hong GS; Lim TH
Singapore Med J; 2002 Sep; 43(9):457-62. PubMed ID: 12568423
[TBL] [Abstract][Full Text] [Related]
8. Completion thyroidectomy in patients with thyroid cancer who initially underwent unilateral operation.
Kim ES; Kim TY; Koh JM; Kim YI; Hong SJ; Kim WB; Shong YK
Clin Endocrinol (Oxf); 2004 Jul; 61(1):145-8. PubMed ID: 15212657
[TBL] [Abstract][Full Text] [Related]
9. Cancer recurrence in papillary thyroid microcarcinoma: a multivariate analysis on 231 patients with a 12-year follow-up.
Pedrazzini L; Baroli A; Marzoli L; Guglielmi R; Papini E
Minerva Endocrinol; 2013 Sep; 38(3):269-79. PubMed ID: 24126547
[TBL] [Abstract][Full Text] [Related]
10. Differentiated thyroid cancer in a Swedish county--long-term results and quality of life.
Malterling RR; Andersson RE; Falkmer S; Falkmer U; Niléhn E; Järhult J
Acta Oncol; 2010 May; 49(4):454-9. PubMed ID: 20092427
[TBL] [Abstract][Full Text] [Related]
11. [Prospective therapy study in differentiated thyroid carcinoma].
Gemsenjäger E; Heitz P; Martina B
Schweiz Med Wochenschr; 1995 Nov; 125(46):2226-36. PubMed ID: 8525342
[TBL] [Abstract][Full Text] [Related]
12. Clinical management and outcome of papillary and follicular (differentiated) thyroid cancer presenting with distant metastasis at diagnosis.
Sampson E; Brierley JD; Le LW; Rotstein L; Tsang RW
Cancer; 2007 Oct; 110(7):1451-6. PubMed ID: 17705176
[TBL] [Abstract][Full Text] [Related]
13. [Differentiated thyroid carcinoma: prognostic factors].
Györy F; Lukács G; Nagy EV; Juhász F; Mezösi E; Szakáll S; Máth J; Balázs G
Magy Seb; 2001 Apr; 54(2):69-74. PubMed ID: 11339092
[TBL] [Abstract][Full Text] [Related]
14. [Loco-regional persistence and recurrences of operated differentiated thyroid cancers. 22 cases on 589 treated patients from 1964 to 1990, follow-up from 5 to 31 years].
Proye C; Gontier A; Capuano G; Combemale F; Carnaille B; Decoulx M; Wemeau JL; Lecomte-Houcke M
Ann Endocrinol (Paris); 1997; 58(3):233-9; discussion 240-1. PubMed ID: 9239247
[TBL] [Abstract][Full Text] [Related]
15. Papillary thyroid microcarcinoma: clinical study and prognosis.
Rodriguez JM; Moreno A; Parrilla P; Sola J; Soria T; Tebar FJ; Aranda F
Eur J Surg; 1997 Apr; 163(4):255-9. PubMed ID: 9161822
[TBL] [Abstract][Full Text] [Related]
16. Differentiated thyroid carcinoma with distant metastases at presentation: prognostic factors and outcome.
Haq M; Harmer C
Clin Endocrinol (Oxf); 2005 Jul; 63(1):87-93. PubMed ID: 15963067
[TBL] [Abstract][Full Text] [Related]
17. Papillary thyroid microcarcinoma in Denmark 1996-2008: a national study of epidemiology and clinical significance.
Londero SC; Krogdahl A; Bastholt L; Overgaard J; Trolle W; Pedersen HB; Bentzen J; Schytte S; Christiansen P; Godballe C;
Thyroid; 2013 Sep; 23(9):1159-64. PubMed ID: 23427917
[TBL] [Abstract][Full Text] [Related]
18. Management and outcome of recurrent well-differentiated thyroid carcinoma.
Palme CE; Waseem Z; Raza SN; Eski S; Walfish P; Freeman JL
Arch Otolaryngol Head Neck Surg; 2004 Jul; 130(7):819-24. PubMed ID: 15262757
[TBL] [Abstract][Full Text] [Related]
19. Prognostic factors and the therapeutic strategy for patients with bone metastasis from differentiated thyroid carcinoma.
Orita Y; Sugitani I; Matsuura M; Ushijima M; Tsukahara K; Fujimoto Y; Kawabata K
Surgery; 2010 Mar; 147(3):424-31. PubMed ID: 20176243
[TBL] [Abstract][Full Text] [Related]
20. [Surgical treatment and long-term efficacy on stage T1-3N0 differentiated thyroid carcinoma].
Li QL; Chen FJ; Zeng ZY; Guo ZM; Song M; Yang AK
Ai Zheng; 2008 Mar; 27(3):299-303. PubMed ID: 18334121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
